NCT06638710View on ClinicalTrials.gov

Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

November 1, 2026

Conditions
Neurocognitive Disorders
Interventions
DRUG

oral administration of midazolam or placebo

If the patient is opposed to a treatment (resistance to care ≥3 on the Pittsburgh scale), the nurse administers an oral dose of midazolam or placebo to the patient according to the random allocation.

Trial Locations (1)

38043

Geriatric department of Grenoble Alpes university hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06638710 - Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care. | Biotech Hunter | Biotech Hunter